scispace - formally typeset
C

Catherine M. Cahill

Researcher at University of California, Los Angeles

Publications -  169
Citations -  10277

Catherine M. Cahill is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Opioid & Nociception. The author has an hindex of 53, co-authored 163 publications receiving 8981 citations. Previous affiliations of Catherine M. Cahill include Westmead Hospital & Black Dog Institute.

Papers
More filters
Journal ArticleDOI

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.

TL;DR: Iron regulation of APP mRNA through the APP 5′-UTR points to a role for iron in the metabolism of APP and confirms that this RNA structure can be a target for the selection of small molecule drugs, such as desferrioxamine and clioquinol, which reduce Aβ peptide burden during Alzheimer's disease.
Journal ArticleDOI

TNF-α and neuropathic pain - a review

TL;DR: The intricate link of TNF-α with other neuro-inflammatory signaling systems (e.g., chemokines and p38 MAPK) has indeed inspired a systems approach perspective for future drug development in treating neuropathic pain.
Journal ArticleDOI

Neuropathic pain: a practical guide for the clinician

TL;DR: A primary care algorithm for treatments with the most favourable risk–benefit profile is proposed, including topical lidocaine, gabapentin, pregabalin, tricyclic antidepressants, mixed serotonin–norepinephrine reuptake inhibitors, tramadol and opioids.
Journal ArticleDOI

Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences.

TL;DR: Enhanced translation of APP mRNA provides a mechanism by which IL-1 influences the pathogenesis of AD, and is homologous to related translational control elements in the 5′-UTR of the light and and heavy ferritin genes.